Recent Posts
Deals•Feb 24, 2026
Slate Medicines Secures $130M Series A Funding Led by RA Capital, Forbion and Foresite Capital
Slate Medicines, a North Carolina‑based biotech startup, announced a $130 million Series A round to fund development of its PACAP‑blocking migraine antibody SLTE‑1009. The round was led by RA Capital, Forbion and Foresite Capital, with participation from an undisclosed biotech investor. The capital will support pre‑clinical and Phase 1 testing slated for mid‑2026.
MedCity News
News•Feb 22, 2026
AI Is Changing Nursing Education and Raising New Graduate Expectations
AI is reshaping nursing education, prompting curricula to incorporate AI documentation, simulation, and analytics tools. Hospitals face acute staffing gaps, with 25% of new nurses leaving within a year and a projected shortage of 63,700 RNs by 2030. Universities are...
By MedCity News
News•Feb 20, 2026
How Arintra’s Coding AI Helped Mercyhealth Boost Revenue by 5%
Mercyhealth, a 6‑hospital system serving northern Illinois and southern Wisconsin, deployed Arintra’s AI‑driven coding platform across 37 sites in 2023. The technology automates chart coding, writes medical codes directly into the EHR, and flags missed reimbursement opportunities. Since implementation, the...
By MedCity News
News•Feb 20, 2026
Proven Methodologies For Ensuring Seamless CRM Migrations In Highly Regulated Environments
CRM migrations in healthcare and life sciences are accelerating amid tighter regulations such as HIPAA, GDPR, and FDA 21 CFR Part 11. Avenga’s Roman Bevz outlines a compliance‑by‑design methodology that starts with mapping data to regulatory obligations and proceeds through risk analysis,...
By MedCity News
News•Feb 19, 2026
Sustaining Clinician Independence: Why Simplicity, Not Consolidation, Is Key to Solving the Mental Health Crisis
The article argues that America’s mental‑health crisis cannot be solved by consolidating providers; instead, preserving clinician independence is essential. While demand outpaces supply, most mental‑health clinicians still operate solo or in small groups, delivering timely, high‑quality care. Consolidation introduces administrative...
By MedCity News
News•Feb 19, 2026
Imaging Data Liquidity: The Foundation of Multimodal Medical Intelligence
Healthcare’s imaging assets—radiology and digital pathology—are evolving from isolated diagnostic tools into a strategic, enterprise‑wide intelligence layer. Current PACS and VNA infrastructures were built for episodic access, limiting data recombination, longitudinal analysis, and outcome linkage. The article argues that achieving...
By MedCity News
News•Feb 19, 2026
Anthropic: It’s “Critical” To Bring Company Products to EHR
Anthropic is pushing its Claude AI model into electronic health record (EHR) systems, arguing that integration is essential for real‑time clinical value. The company highlighted a roster of 25 healthcare partners, including Abridge, Novo Nordisk, Genmab and Banner Health, to showcase both...
By MedCity News
News•Feb 18, 2026
Solera Health Launches Behavioral Health Network with Calm and Lyra
Solera Health announced a new behavioral health network that links its HALO platform with Calm Health and Lyra Health. The service directs members to self‑guided apps or therapist‑led care based on their reported needs, expanding support beyond anxiety and depression...
By MedCity News
News•Feb 18, 2026
Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making
Pharma launches are missing the mark 58% of the time, a failure rate driven by poor market insight and fragmented decision‑making. Accelerating market‑access planning from pre‑Phase 2 and integrating real‑world data can give companies a strategic north star. Purpose‑built AI tools...
By MedCity News
Deals•Feb 18, 2026
Eli Lilly Pays $100M for Rights to CSL’s Clazakizumab
Eli Lilly announced it will pay $100 million to CSL Limited for the rights to the IL‑6‑blocking antibody clazakizumab, with CSL retaining rights for cardiovascular prevention in end‑stage kidney disease patients. The deal includes an upfront payment and potential milestone and...
MedCity News
News•Feb 17, 2026
Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption
Regulatory bodies are reshaping medical‑device oversight to prioritize usability, interoperability, and cybersecurity, accelerating adoption in both hospitals and homes. New human‑factors guidelines, AI/ML lifecycle controls, and post‑market surveillance tools ensure devices are safe, intuitive, and adaptable to real‑world conditions. Manufacturers...
By MedCity News
News•Feb 16, 2026
From Pilots to Protocols: Why VR Therapy Needs Dosage Standards to Become Real Clinical Care
Virtual reality (VR) therapy shows rapid clinical effects but remains confined to pilot studies due to a lack of standardized dosage protocols. Researchers highlight wide variation in session length, frequency, and content across studies, preventing reliable comparison and scaling. The...
By MedCity News
News•Feb 16, 2026
When Health Dollars Move to Individuals, Infrastructure Will Decide Who Wins
The article examines a proposed federal framework that would shift health‑affordability dollars into individual‑controlled accounts, highlighting that ownership of the payment infrastructure will decide market winners. It points to the rapid growth of high‑deductible plans, Health Savings Accounts exceeding $100 billion,...
By MedCity News
News•Feb 13, 2026
Closing the CKD Care Gap with Value-Based Care Models
Chronic kidney disease (CKD) impacts more than one in seven U.S. adults and kills more people annually than breast or prostate cancer, yet it remains under‑diagnosed, especially among women and minority groups. Value‑based care (VBC) models shift focus to early...
By MedCity News
News•Feb 13, 2026
AI Can’t Improve Healthcare if Clinicians and Staff Aren’t Trained to Use, Orchestrate It
Healthcare systems are rapidly deploying AI for diagnosis, documentation, scheduling and patient communication, but many clinicians and support staff lack the training to use these tools effectively. The article argues that one‑time, checkbox‑style training creates risks such as automation bias...
By MedCity News
News•Feb 12, 2026
Talkiatry Rakes In $210M to Scale Virtual Psychiatry Group
Telepsychiatry startup Talkiatry closed a $210 million Series D round, bringing total capital raised above $400 million. The funding, led by Perceptive Advisors with participation from Andreessen Horowitz and others, will support scaling its virtual psychiatry platform, which currently employs over 800 psychiatrists...
By MedCity News
News•Feb 12, 2026
A Guide to the Best Disaster Recovery Solutions for Health Care Organizations
Healthcare providers face heightened risk from cyber attacks and natural disasters, making robust disaster recovery essential. Vendors such as Dataprise, Veeam, Acronis, Zerto, and Carbonite offer cloud, hybrid, and on‑premises solutions that promise rapid recovery, HIPAA compliance, and proactive monitoring....
By MedCity News
News•Feb 12, 2026
Blinded by Science: The Importance of RWD and Post-Market Surveillance
The explosive uptake of GLP‑1 drugs—now used by roughly 12% of U.S. adults—has spotlighted both their therapeutic benefits and emerging safety concerns. Post‑market surveillance, leveraging real‑world data (RWD), is uncovering rare vision‑related adverse events that clinical trials missed. AI‑driven analytics...
By MedCity News